World
Health groups aim to reach 2M people with HIV prevention drug

GENEVA, Switzerland — Several giant US and international groups focused on fighting HIV and AIDS on Tuesday unveiled a plan to swiftly provide affordable access to a possibly 'game-changing' HIV prevention drug in lower-income countries.

The Global Fund, a partnership set up to battle AIDS, tuberculosis and malaria, said it had joined forces with PEPFAR, the main US program aimed at reducing the spread of HIV/AIDS, to 'rapidly provide affordable and equitable access to twice-yearly injectable lenacapavir for HIV pre-exposure prophylaxis (PrEP).'

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here